IEVL:LSE:LSE-iShares Edge MSCI Europe Value Factor UCITS ETF EUR (Acc) (EUR)

ETF | Others |

Last Closing

USD 9.873

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 636.56B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

N/A

USD 260.39B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing IEVL:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.27% 94% A 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.27% 94% A 87% B+
Trailing 12 Months  
Capital Gain 22.33% 90% A- 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.33% 89% A- 81% B-
Trailing 5 Years  
Capital Gain 77.48% 79% B- 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 77.48% 77% C+ 81% B-
Average Annual (5 Year Horizon)  
Capital Gain 14.84% 77% C+ 77% C+
Dividend Return 14.84% 77% C+ 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.06% 51% F 69% C-
Risk Adjusted Return 105.58% 90% A- 94% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike